Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Day One Biopharmaceuticals, Inc. (DAWN)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 87,040,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co. is engaged in developing and commercializing targeted therapies for patients with genomically-defined cancers. Co.'s main product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Co.'s second product candidate, pimasertib, is an oral, highly-selective small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK), a well-characterized key signaling node in the RAS/mitogen-activated protein kinase pathway.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,244,684 4,978,018
Total Buy Value $0 $0 $24,978,318 $65,978,328
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 4 7
Total Shares Sold 225,453 235,538 246,104 4,525,329
Total Sell Value $3,837,225 $3,955,119 $4,100,690 $62,122,635
Total People Sold 4 4 4 8
Total Sell Transactions 14 18 25 103
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 168
  Page 2 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   York Charles N Ii COO, CFO and Secretary   •       –      –    2023-08-17 4 S $13.86 $12,779 D/D (922) 267,501     -
   Blackman Samuel C. Head of Research and Developme   •       –      –    2023-08-17 4 S $13.86 $9,258 D/D (668) 1,236,319     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-08-15 4 OE $0.00 $0 D/D 8,312 707,220     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2023-08-15 4 OE $0.00 $0 D/D 3,625 268,423     -
   Blackman Samuel C. Head of Research and Developme   •       –      –    2023-08-15 4 OE $0.00 $0 D/D 2,624 1,236,987     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-07-01 4 GA $0.00 $0 I/I 570,251 270,226     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-07-01 4 GD $0.00 $0 I/I 329,963 251,636     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-07-01 4 GD $0.00 $0 D/D 240,288 698,908     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-07-01 4 A $0.00 $0 I/I 240,288 240,288     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-07-01 4 D $0.00 $0 D/D (240,288) 939,196     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2023-06-09 4 B $13.00 $9,999,990 D/D 769,230 11,453,868 2.44     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2023-06-05 4 AS $16.00 $19,664 D/D (1,229) 1,234,363     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-05-16 4 S $13.12 $40,732 D/D (3,104) 1,179,484     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2023-05-16 4 S $13.12 $9,081 D/D (692) 1,235,592     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2023-05-16 4 S $13.12 $12,532 D/D (955) 264,798     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-05-15 4 OE $0.00 $0 D/D 8,312 1,182,588     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2023-05-15 4 OE $0.00 $0 D/D 2,624 1,236,284     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2023-05-15 4 OE $0.00 $0 D/D 3,625 265,753     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2023-03-10 4 AS $18.05 $180,484 D/D (10,000) 1,233,660     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-03-07 4 AS $20.01 $250,114 D/D (12,500) 1,174,276     -
   Papanek Julie Director   –       •      –    2023-03-01 4 AS $18.61 $465,303 I/I (25,000) 330,000     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2023-02-17 4 AS $20.03 $187,790 D/D (9,377) 262,128     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2023-02-16 4 S $19.57 $13,192 D/D (674) 1,243,660     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2023-02-16 4 S $19.57 $18,203 D/D (930) 271,505     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-02-16 4 S $19.57 $59,150 D/D (3,022) 1,186,776     -
  168 Records found
  1  2  3  4  5  6  7   
  Page 2 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us